217 related articles for article (PubMed ID: 22191614)
1. PET measurements of cAMP-mediated phosphodiesterase-4 with (R)-[11C]rolipram.
Kenk M; Thomas A; Lortie M; Dekemp R; Beanlands RS; Dasilva JN
Curr Radiopharm; 2011 Jan; 4(1):44-58. PubMed ID: 22191614
[TBL] [Abstract][Full Text] [Related]
2. In vivo selective binding of (R)-[11C]rolipram to phosphodiesterase-4 provides the basis for studying intracellular cAMP signaling in the myocardium and other peripheral tissues.
Kenk M; Greene M; Thackeray J; deKemp RA; Lortie M; Thorn S; Beanlands RS; DaSilva JN
Nucl Med Biol; 2007 Jan; 34(1):71-7. PubMed ID: 17210463
[TBL] [Abstract][Full Text] [Related]
3. Increasing synaptic noradrenaline, serotonin and histamine enhances in vivo binding of phosphodiesterase-4 inhibitor (R)-[11C]rolipram in rat brain, lung and heart.
Lourenco CM; Kenk M; Beanlands RS; DaSilva JN
Life Sci; 2006 Jun; 79(4):356-64. PubMed ID: 16499932
[TBL] [Abstract][Full Text] [Related]
4. Behaviour of [11C]R(-)- and [11C]S(+)-rolipram in vitro and in vivo, and their use as PET radiotracers for the quantificative assay of PDE4.
Parker CA; Matthews JC; Gunn RN; Martarello L; Cunningham VJ; Dommett D; Knibb ST; Bender D; Jakobsen S; Brown J; Gee AD
Synapse; 2005 Mar; 55(4):270-9. PubMed ID: 15668983
[TBL] [Abstract][Full Text] [Related]
5. Effects of cAMP-dependent protein kinase activator and inhibitor on in vivo rolipram binding to phosphodiesterase 4 in conscious rats.
Itoh T; Abe K; Hong J; Inoue O; Pike VW; Innis RB; Fujita M
Synapse; 2010 Feb; 64(2):172-6. PubMed ID: 19852069
[TBL] [Abstract][Full Text] [Related]
6. PET of (R)-11C-rolipram binding to phosphodiesterase-4 is reproducible and sensitive to increased norepinephrine in the rat heart.
Thomas AJ; DaSilva JN; Lortie M; Renaud JM; Kenk M; Beanlands RS; deKemp RA
J Nucl Med; 2011 Feb; 52(2):263-9. PubMed ID: 21270457
[TBL] [Abstract][Full Text] [Related]
7. PET Imaging of Phosphodiesterase-4 Identifies Affected Dysplastic Bone in McCune-Albright Syndrome, a Genetic Mosaic Disorder.
Weidner LD; Wakabayashi Y; Stolz LA; Collins MT; Guthrie L; Victorino M; Chung J; Miller W; Zoghbi SS; Pike VW; Fujita M; Innis RB; Boyce AM
J Nucl Med; 2020 Nov; 61(11):1672-1677. PubMed ID: 32284396
[TBL] [Abstract][Full Text] [Related]
8. Downregulation of brain phosphodiesterase type IV measured with 11C-(R)-rolipram positron emission tomography in major depressive disorder.
Fujita M; Hines CS; Zoghbi SS; Mallinger AG; Dickstein LP; Liow JS; Zhang Y; Pike VW; Drevets WC; Innis RB; Zarate CA
Biol Psychiatry; 2012 Oct; 72(7):548-54. PubMed ID: 22677471
[TBL] [Abstract][Full Text] [Related]
9. PET measurement of the in vivo affinity of 11C-(R)-rolipram and the density of its target, phosphodiesterase-4, in the brains of conscious and anesthetized rats.
Itoh T; Abe K; Zoghbi SS; Inoue O; Hong J; Imaizumi M; Pike VW; Innis RB; Fujita M
J Nucl Med; 2009 May; 50(5):749-56. PubMed ID: 19372471
[TBL] [Abstract][Full Text] [Related]
10. Imaging cAMP-specific phosphodiesterase-4 in human brain with R-[11C]rolipram and positron emission tomography.
DaSilva JN; Lourenco CM; Meyer JH; Hussey D; Potter WZ; Houle S
Eur J Nucl Med Mol Imaging; 2002 Dec; 29(12):1680-3. PubMed ID: 12458404
[TBL] [Abstract][Full Text] [Related]
11. Powerful relaxation of phosphodiesterase type 4 inhibitor rolipram in the pig and human bladder neck.
Ribeiro ASF; Fernandes VS; Martínez-Sáenz A; Martínez P; Barahona MV; Orensanz LM; Blaha I; Serrano-Margüello D; Bustamante S; Carballido J; García-Sacristán A; Prieto D; Hernández M
J Sex Med; 2014 Apr; 11(4):930-941. PubMed ID: 24754330
[TBL] [Abstract][Full Text] [Related]
12. cAMP signaling in brain is decreased in unmedicated depressed patients and increased by treatment with a selective serotonin reuptake inhibitor.
Fujita M; Richards EM; Niciu MJ; Ionescu DF; Zoghbi SS; Hong J; Telu S; Hines CS; Pike VW; Zarate CA; Innis RB
Mol Psychiatry; 2017 May; 22(5):754-759. PubMed ID: 27725657
[TBL] [Abstract][Full Text] [Related]
13. Use of a column-switching high-performance liquid chromatography method to assess the presence of specific binding of (R)- and (S)-[(11)C]rolipram and their labeled metabolites to the phosphodiesterase-4 enzyme in rat plasma and tissues.
Kenk M; Greene M; Lortie M; Dekemp RA; Beanlands RS; Dasilva JN
Nucl Med Biol; 2008 May; 35(4):515-21. PubMed ID: 18482689
[TBL] [Abstract][Full Text] [Related]
14. Imaging of cAMP-specific phosphodiesterase-IV: comparison of [11C]rolipram and [11C]Ro 20-1724 in rats.
Lourenco CM; DaSilva JN; Warsh JJ; Wilson AA; Houle S
Synapse; 1999 Jan; 31(1):41-50. PubMed ID: 10025682
[TBL] [Abstract][Full Text] [Related]
15. Roles of GRK and PDE4 activities in the regulation of beta2 adrenergic signaling.
Xin W; Tran TM; Richter W; Clark RB; Rich TC
J Gen Physiol; 2008 Apr; 131(4):349-64. PubMed ID: 18347080
[TBL] [Abstract][Full Text] [Related]
16. Phosphodiesterase 4 in macrophages: relationship between cAMP accumulation, suppression of cAMP hydrolysis and inhibition of [3H]R-(-)-rolipram binding by selective inhibitors.
Kelly JJ; Barnes PJ; Giembycz MA
Biochem J; 1996 Sep; 318 ( Pt 2)(Pt 2):425-36. PubMed ID: 8809029
[TBL] [Abstract][Full Text] [Related]
17. A Nonhuman Primate PET Study: Measurement of Brain PDE4 Occupancy by Roflumilast Using (R)-[
Takano A; Uz T; Garcia-Segovia J; Tsai M; Lahu G; Amini N; Nakao R; Jia Z; Halldin C
Mol Imaging Biol; 2018 Aug; 20(4):615-622. PubMed ID: 29441434
[TBL] [Abstract][Full Text] [Related]
18. Interaction between the antidepressant-like behavioral effects of beta adrenergic agonists and the cyclic AMP PDE inhibitor rolipram in rats.
Zhang HT; Huang Y; Mishler K; Roerig SC; O'Donnell JM
Psychopharmacology (Berl); 2005 Oct; 182(1):104-15. PubMed ID: 16010541
[TBL] [Abstract][Full Text] [Related]
19. Short-term or long-term treatments with a phosphodiesterase-4 (PDE4) inhibitor result in opposing agonist-induced Ca(2+) responses in endothelial cells.
Campos-Toimil M; Keravis T; Orallo F; Takeda K; Lugnier C
Br J Pharmacol; 2008 May; 154(1):82-92. PubMed ID: 18311187
[TBL] [Abstract][Full Text] [Related]
20. Regulation of cyclic AMP in rat pulmonary microvascular endothelial cells by rolipram-sensitive cyclic AMP phosphodiesterase (PDE4).
Thompson WJ; Ashikaga T; Kelly JJ; Liu L; Zhu B; Vemavarapu L; Strada SJ
Biochem Pharmacol; 2002 Feb; 63(4):797-807. PubMed ID: 11992650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
